Measuring a woman's bone mineral density can provide additional information that may help more accurately determine a woman's risk of developing breast cancer. The study's results suggest that incorporating bone mineral density tests with current risk assessments might significantly improve physicians' ability to predict breast cancer risk in older, postmenopausal women.
Bone mineral density testing is done to diagnose osteoporosis and help assess the risk of fractures. Low bone mineral density is linked to higher risk of fractures, while normal density is linked to lower risk of fractures. It is possible that over a woman's lifetime, hormonal and other factors that lead to higher bone mineral density can also lead to higher risk of breast cancer.
Osteoporosis
Osteoporosis is a bone disease that leads to an increased risk of fractures. The bone mass is reduced and the bones are porous, thereby resulting in weakness of the skeletal system of the body.
Advertisement
Studies have found an association between higher bone mineral density and higher breast cancer risk, and bone mineral density tests have been proposed as a potential addition to breast cancer risk models. This study, supported by Eli Lilly & Company, is the first to investigate the relationships among bone mineral density, traditional breast cancer risk assessment tool results, and breast cancer incidence among the same group of postmenopausal women.
To investigate these relationships, Dr. Zhao Chen of the University of Arizona Mel and Enid Zuckerman College of Public Health and her colleagues studied approximately 10,000 post-menopausal women (average age 63) taking part in the Women's Health Initiative, a study conducted in 40 clinical centers throughout the United States and supported by the National Heart, Lung and Blood Institute of the National Institutes of Health.
![Cycing Could Reduce Bone Density]( "Cycing Could Reduce Bone Density")
Cycling could lead to lower bone density, known as osteopenia. Doctors suggest bone-loading exercise as a counter.
The researchers assessed the women's initial bone mineral density level as well as their score on the Gail risk model, a well known and commonly used tool that estimates five year and lifetime risk of invasive breast cancer for women 35 years of age or older. They then followed the women for an average of approximately 8 years, noting which women developed breast cancer.
As expected, the study found that women with a high Gail score had a 35 percent increased risk of developing breast cancer compared to women with a lower Gail score. But the study also found a 25 percent increase in the risk of developing the disease with each unit increase in total hip bone mineral density t-score. While the two scores were independent of each other, women who had the highest scores on both assessments had a much higher risk in breast cancer.
The findings suggest that adding bone mineral density to currently used risk assessment tools may significantly improve the prediction of breast cancer risk.
"Future studies should investigate whether incorporating bone mineral density and Gail score with other risk factors, such as breast density, can further improve the identification of women at high risk for developing breast cancer," the authors wrote.
This study also suggests that bone mineral density is a potential alternative for predicting breast cancer risk in postmenopausal women if Gail score is not available. Additional studies are needed to determine if the results from this investigation are applicable to a broader group of women, including minorities.
The findings do not change the use of bone mineral density testing to diagnose osteoporosis or the need to treat osteoporosis in order to reduce the risk of fractures.
Source: Eurekalert
KAR
Cycing Could Reduce Bone Density
Cycling could lead to lower bone density, known as osteopenia. Doctors suggest bone-loading exercise as a counter.
Advertisement
The researchers assessed the women's initial bone mineral density level as well as their score on the Gail risk model, a well known and commonly used tool that estimates five year and lifetime risk of invasive breast cancer for women 35 years of age or older. They then followed the women for an average of approximately 8 years, noting which women developed breast cancer.
As expected, the study found that women with a high Gail score had a 35 percent increased risk of developing breast cancer compared to women with a lower Gail score. But the study also found a 25 percent increase in the risk of developing the disease with each unit increase in total hip bone mineral density t-score. While the two scores were independent of each other, women who had the highest scores on both assessments had a much higher risk in breast cancer.
The findings suggest that adding bone mineral density to currently used risk assessment tools may significantly improve the prediction of breast cancer risk.
"Future studies should investigate whether incorporating bone mineral density and Gail score with other risk factors, such as breast density, can further improve the identification of women at high risk for developing breast cancer," the authors wrote.
This study also suggests that bone mineral density is a potential alternative for predicting breast cancer risk in postmenopausal women if Gail score is not available. Additional studies are needed to determine if the results from this investigation are applicable to a broader group of women, including minorities.
The findings do not change the use of bone mineral density testing to diagnose osteoporosis or the need to treat osteoporosis in order to reduce the risk of fractures.
Source: Eurekalert
KAR
Too Much Chocolate Could Have A Negative Effect On Bone Density
Too much of that delicious brown bar could land you with fractures, warn experts.
Advertisement
Advertisement
|
Advertisement
Recommended Readings
Latest Women Health News
Laser speckle wearable gadget helps in the early detection of postpartum hemorrhage, potentially reducing maternal mortality rates.
More than 90% of previously unexplained pregnancy losses or miscarriages were accurately determined by placental testing.
Fetal growth restriction impacts around 60,000 infants annually in Europe and the United States.
For women under 40, trying to conceive, timing intercourse around the fertile period using a urine ovulation test increases the chances of pregnancy.
Oophorectomy's adverse effects raise questions about risk-benefit balance, especially for average ovarian cancer risk women.
